Medican Enterprises (MDCN) Stock Statistics & Valuation Metrics
Total Valuation
Medican Enterprises has a market cap or net worth of $46.55K. The enterprise value is $2.88T.
- Market Cap
- $46.55K
- Enterprise Value
- $2.88T
Share Statistics
Medican Enterprises has 46,544,977,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 46,544,977,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Medican Enterprises’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 1.53%.
- Return on Equity (ROE)
- 0.22
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 1.53%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 869.67K
- Profits Per Employee
- 2.12M
- Employee Count
- 3
- Asset Turnover
- 0.05
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Medican Enterprises is -3.38. Medican Enterprises’s PEG ratio is -0.03.
- PE Ratio
- -3.38
- PS Ratio
- 0.00
- PB Ratio
- 0.14
- Price to FCF
- -0.14
- Price to Operating Cash Flow
- -0.19
- PEG Ratio
- -0.03
Income Statement
In the last 12 months, Medican Enterprises had revenue of 2.61M and earned 6.35M in profits. Earnings per share was 0.00.
- Revenue
- 2.61M
- Gross Profit
- 1.26M
- Operating Income
- 738.66K
- Pretax Income
- 6.35M
- Net Income
- 6.35M
- EBITDA
- 7.07M
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 9.90M and capital expenditures 0, giving a free cash flow of 9.90M billion.
- Operating Cash Flow
- 9.90M
- Free Cash Flow
- 9.90M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Medican Enterprises pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -736.08%
- Earnings Yield
- -29.62%
Stock Price Statistics
- Beta
- -146.62
- 52-Week Price Change
- ―
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Medican Enterprises as a current ratio of 0.00, with Debt / Equity ratio of 69.71%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 5088.66
- Net Debt to EBITDA
- 2.79
- Interest Coverage Ratio
- 8.86
Taxes
In the past 12 months, Medican Enterprises has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Medican Enterprises EV to EBITDA ratio is -18.70, with an EV/FCF ratio of -1.07.
- EV to Sales
- 0.00
- EV to EBITDA
- -18.70
- EV to Free Cash Flow
- -1.07
- EV to Operating Cash Flow
- -1.07
Balance Sheet
Medican Enterprises has $75.30K in cash and marketable securities with $19.82M in debt, giving a net cash position of -$19.74M billion.
- Cash & Marketable Securities
- $75.30K
- Total Debt
- $19.82M
- Net Cash
- -$19.74M
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Medican Enterprises is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
